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A B S T R A C T
Macrophage-colony stimulating factor (M-CSF) and granulocyte macrophage-colony stimulating factor (GM-
CSF) play key roles in the differentiation of macrophages and dendritic cells (DCs). We examined the effect of
treatment with M-CSF-containing macrophage medium or GM-CSF-containing DC medium upon the phenotype
of murine bone marrow-derived macrophages and DCs. Culture of macrophages for 5 days in DC medium re-
duced F4/80 expression and increased CD11c expression with cells effectively stimulating T cell proliferation in
a mixed lymphocyte reaction. DC medium treatment of macrophages significantly reduced phagocytosis of both
apoptotic cells and latex beads and strongly induced the expression of the chemokine receptor CCR7 known to be
involved in DC trafficking to lymph nodes. Lysates of obstructed murine kidneys expressed both M-CSF and GM-
CSF though M-CSF expression was dominant (M-CSF:GM-CSF ratio ∼30:1). However, combination treatment
with both M-CSF and GM-CSF (ratio 30:1) indicated that small amounts of GM-CSF skewed macrophages to-
wards a DC–like phenotype. To determine whether macrophage phenotype might be modulated in vivo we
tracked CD45.1+ bone marrow-derived macrophages intravenously administered to CD45.2+ mice with uni-
lateral ureteric obstruction. Flow cytometry of enzyme dissociated kidneys harvested 3 days later indicated
CD11c and MHC Class II upregulation by adoptively transferred CD45.1+ cells with CD45.1+ cells evident in
draining renal lymph nodes. Our data suggests that GM-CSF modulates mononuclear phagocyte plasticity, which
likely promotes resolution of injury and healing in the injured kidney.
1. Introduction
Renal mononuclear phagocytes play a key role in innate and
adaptive immunity in renal health and disease (reviewed in Nelson
et al., 2012) and have been described as either macrophages (Mφ) or
dendritic cells (DCs) according to various criteria (Rogers et al., 2014).
Mφ have historically been ascribed various roles in phagocytosis, renal
inflammation, fibrosis and regeneration (Duffield, 2010; Wang and
Harris, 2011; Anders and Ryu, 2011), whereas DCs are thought to be
specialized for the capture, processing and presentation of antigen and
the subsequent instruction of immune cells with both pathogenic and
tolerogenic roles being described (Teteris et al., 2011; Hochheiser et al.,
2011). Considerable flexibility, heterogeneity, and complexity is re-
cognized within the myeloid–monocyte developmental lineage (Hume
et al., 2002; Mosser and Edwards, 2008). Recent work has shown that
renal tissue resident Mφ populations have different developmental
origins, with subsets comprised of monocyte-derived cells, but also of
embryonic origin (Ginhoux and Guilliams, 2016). In the kidney,
mononuclear phagocytes have been found to comprise of various
groups based on combinations of cell surface markers (e.g. CD11c, F4/
80, CD11b) and phenotype/function (Kawakami et al., 2013; Viehmann
et al., 2018; Lee et al., 2018). Kawakami et al reported the presence of
five discrete subsets of renal mononuclear phagocyte in the steady state,
most of which display phenotypic and functional characteristics of both
Mφ and DCs i.e. they are positive for both CD11c and F4/80, and dis-
play both phagocytic and antigen presentation abilities (Kawakami
et al., 2013).
The discrete growth and differentiation factors macrophage colony-
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stimulating factor (M-CSF) and granulocyte macrophage colony-sti-
mulating factor (GM-CSF) induce the differentiation of Mφ and DCs
from hematopoietic progenitors (Kipari et al., 2006; Inaba et al., 1992).
Mφ and DCs may be generated in vitro and, although they are unlikely
to have an exact counterpart in vivo, these cells have been used to
dissect various cellular functions of Mφ and DC such as the interaction
with apoptotic cells (Lucas et al., 2006). Also, recent work has de-
monstrated the beneficial effects of using bone marrow-derived Mφ as a
substrate for cell therapy in acute kidney injury (Ferenbach et al.,
2010), glomerulonephritis (Wilson et al., 2002), and renal fibrosis
(Yamagishi et al., 2001). However, it is unclear whether such cells
undergo phenotypic changes following localisation in inflamed tissues
as a result of exposure to tissue-derived growth and differentiation
factors.
In this study, we examined the phenotypic and functional plasticity
of murine bone marrow-derived Mφ (BMMφ) and DCs (BMDC) exposed
to M-CSF or GM-CSF-containing medium either sequentially or in
combination. Key phenotypic readouts included the flow cytometric
analysis of cell surface markers (F4/80, CD11c & MHC Class II) and
realtime PCR for the chemokine receptor CCR7 involved in DC egress
from tissues to lymphoid organs. Key functional readouts included
phagocytosis (Lucas et al., 2006), and stimulation of T cell proliferation
in the mixed lymphocyte reaction (MLR). In this study, we determined
the kinetics of renal M-CSF and GM-CSF protein expression for the first
time during unilateral ureteric obstruction (UUO) and tracked the fate
and phenotype of CD45.1+ BMMφ adoptively transferred to CD45.2+
C57B/6 mice with UUO. M-CSF and GM-CSF are known to be important
regulators of mononuclear phagocyte plasticity. This work shows that
exposure to even small quantities of GM-CSF in the inflamed kidney
promotes the acquisition of features in Mφ more commonly associated
with DCs, that likely promote the resolution of inflammation and ef-
fective renal repair.
2. Materials and methods
2.1. Experimental mice
6–10 week old male mice on the C57BL/6 background (CD45.1 or
CD45.2) were bred and maintained in conventional barrier unit facil-
ities at the University of Edinburgh or purchased from Harlan, UK.
These units are regularly tested in accordance with the Felasa 2014
recommendations, which involves testing for various infectious agents,
including parasites.
2.2. Ethics statement
All animal work was compliant with IACUC guidelines, conducted
in accordance with the UK Government Animals (Scientific Procedures)
Act 1986 and was approved by the University of Edinburgh Ethical
Review Committee.
2.3. Cell culture
Mφ medium consisted of either (i) RPMI (GIBCO, UK) supplemented
with 25% FBS (GIBCO), 25% L929 supernatant (a source of M-CSF),
2 mM L-glutamine, 0.25U/ml penicillin and 100 μg/ml streptomycin or
(ii) 20 ng/ml recombinant murine (rm) M-CSF (Invitrogen, UK) in
complete RPMI (10% FBS, L-glutamine and Penicillin/Streptomycin).
DC medium consisted of either (i) 10% GM-CSF conditioned medium in
complete RPMI or (ii) 20 ng/ml rm GM-CSF (Invitrogen, UK) added to
complete RPMI.
BMMφ and BMDC were prepared from C57BL/6 bone marrow as
previously described (Kipari et al., 2006). Cells were plated (7.5 × 106
cells/plate), cultured in Mφ medium with adherent Mφ evident at day
7. BMDC were similarly generated using DC medium with supplemen-
tary medium added at days 2 and 4. DCs were present as non-adherent
cells at day 7. In some experiments, bone marrow cells were cultured
for 7 days in Teflon pots. In medium switching experiments, day 7
adherent Mφ and non-adherent DCs were removed to fresh 6-well
culture plates (1–1.5 × 106 cells/ well in 3 ml media) and cultured for a
further 5 days in either conventional or recombinant Mφ medium, DC
medium or a mix of Mφ/DC media (i.e. Mφ/Mφ, Mφ/DC, DC/DC, DC/
Mφ, Mφ/Mix and DC/Mix). Following peritoneal lavage, peritoneal Mφ
were purified by adhesion to tissue culture plastic.
2.4. Unilateral ureteric obstruction and enzymatic dissociation of organs
UUO was performed in anaesthetized 6–10 week male C57BL/6
mice as previously described (Kipari et al., 2006). The obstructed left
kidneys, and livers, were diced into small pieces and incubated in
1.6 mg/ml Collagenase B (Roche, West Sussex, UK) and 100 μg/ml
DNAse 1 (Ambion, Warrington, UK) in RPMI medium at 37 °C for
45 min with gentle agitation. Tissue was centrifuged (300 g× 5 min)
and incubated with 100 μg/ml DNAse 1 in RPMI medium for 15 min at
room temperature. Following centrifugation and resuspension in 1 ml
RPMI, digested kidney and liver tissue, and spleens were gently pressed
through a 40-μm cell strainer using a flattened pestle. Cells were cen-
trifuged (300 g× 5 min) and red blood cells lysed with lysis buffer
(Sigma) for 5–10 min at room temperature before washing once in PBS.
The resultant single cell suspension was then analyzed by flow cyto-
metry.
2.5. Flow Cytometry and fluorescence associated cell sorting (FACs)
2.5 × 105 −1 × 106 cells from cell culture or tissue digest, were
blocked with 10% mouse serum (20 min on ice) and incubated for
30 min on ice with the fluorochrome conjugated primary antibody di-
luted in PBS with 10% mouse serum. Antibodies included anti-F4/80-
PerCp Cy5.5 (1:50), anti-F4/80-APC (1:100), anti-CD11c-APC (1:100),
anti-CD11c-PE (1:100), anti-MHC class II-FITC (1:100), anti-CD11b-
APC (1:100) and anti-CD45.1-Pacific Blue (1:100) and appropriate
isotype control Abs. The cells were then washed once in PBS, some fixed
in 5% formalin before acquisition and analysis (BD FACStation,
FacsAria and FlowJo software). Propidium Iodide (1:1000) was added
before acquisition to quantify dead cells. CD11b + cells were sorted
from naïve and post-UUO kidneys by FACS using the FACsAria II. These
cells were frozen at −80 °C in TRIizol Reagent (Invitrogen) before RNA
extraction and real-time RT-PCR for CCR7.
2.6. Phagocytosis assay
BMMφ underwent various treatments before being incubated with
either CM green labeled apoptotic thymocytes or fluorescent beads
(10:1 ratio) for 60 min. Cells were vigorously washed and detached
from the plates prior to quantification of phagocytosis by flow cyto-
metry.
2.7. RNA extraction and real-time RT PCR
RNA was recovered from cells by resuspension in TRIzol reagent
(Invitrogen). Total RNA was extracted and approximately 1 μg of RNA
used to synthesize cDNA using MMLV reverse transcriptase (Stratagene,
UK). Relative quantification of CCR7 was measured by real-time PCR,
using the 7500 Fast Real-Time PCR System (Applied Biosystems) with
the expression level normalized to the housekeeping gene β-actin. PCR
amplifications were performed in a total volume of 20 μl containing 1 μl
cDNA, 4 mM MgCl2, 0.3 mM primers and the SYBR Green I mix.
Amplifications were performed in the following conditions: 30 s dena-
turation at 95 °C, 5 s annealing of primers at 55 °C and 12 s elongation
at 72 °C, for 40–50 cycles. Primers for PCR analysis were:
β-Actin: TGGAATCCTGTGGCATCCATGAAAC, TAAAACGCAGCTCA
GTAACAGTCCG.
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Fig. 1. Macrophages can be induced to adopt properties characteristic of dendritic cells and vice versa. Bone marrow cells were grown in macrophage (Mφ) or
dendritic cell (DC) media for 7 days prior to assessment of cell surface expression of F4/80 (a), CD11c (b) and MHC Class II (c) by flow cytometry. The level of
expression is expressed as mean fluorescent intensity (MFI). Day 7 bone marrow-derived Mφ and DCs were then washed and incubated for a further 5 days in DC
medium or Mφ medium respectively. Control Mφ and DCs underwent further culture in Mφ or DC medium respectively. At day 12, cells were recovered and the
expression of F4/80 (d), CD11c (e) and MHC Class II (f) was determined. Again, day 7 bone marrow-derived Mφ and DCs were either switched to DC or Mφ medium
for a further 5 days. Now cells were recovered at days 8, 10 and 12 and real-time PCR undertaken for CCR7 mRNA expression (g). Day 12 cells from control Mφ or DC
cultures or ‘medium switched’ cultures from C57BL/6 mice were replated with splenocytes from BALB/c animals for 48 h. 1 mCi of [3 H]-TdR was added to each well
and plates incubated overnight before harvesting and counting using a liquid scintillation counter to measure T cell proliferation. Data expressed as counts per minute
(cpm) (h). Results are representative of multiple experiments (> 3). * p < 0.05, ** p < 0.01, ***p < 0.




2.8. Mixed leukocyte reaction
C57BL/6 BMMφ and BMDC treated with Mφ medium or DC
medium were co-cultured (1 × 105 cells/well) in 96-well flat-bottomed
plates with splenocytes from BALB/c mice. After 48 h, 1μCi of [3H]-TdR
in 10 μl complete medium was added to each well and plates incubated
overnight before harvesting and counting using a liquid scintillation
counter (Microbeta 1450, Trilux). Quadruplicate measurements per
sample were performed and results expressed as counts per minute.
2.9. Fluorescent cell labeling
Cells were labeled with the PKH67 Green Fluorescent Cell Linker Kit
for General Cell Membrane Labeling (Sigma) according to the manu-
facturer’s instructions (Sigma). Briefly, cells were washed in serum free
RPMI medium, suspended in Diluent A (Sigma) and then mixed with an
equal volume of dye working solution (containing PKH green). After
incubation for 2–5 min, FBS was added for one minute before cells were
washed 3 times in complete RPMI (10% FBS, pen/strep, L-glut).
Labeling efficiency was then assessed by flow cytometry.
2.10. M-CSF and GM-CSF protein measurement
Mice underwent UUO and the obstructed kidneys removed on days
3, 5 and 7 (3 mice per time point, 5 experiments performed). 30 mg of
snap frozen control or obstructed kidney tissue was placed in 300 μl
RIPA buffer (plus protease inhibitors), homogenised using plastic pes-
tles and placed on ice for 10 min. Supernatants were removed following
centrifugation (10 min. at 10,000 g) and the concentrations of M-CSF
and GM-CSF were measured by ELISA (R&D Systems, UK) according to
manufacturer’s instructions.
2.11. Adoptive transfer of bone marrow-derived macrophages
BMMφ were generated by culture of bone marrow cells from
CD45.1+ C57BL/6 mice in Mφ medium in Teflon Pots for 7 days.
5 × 106 mature CD45.1+ BMMφ were injected intravenously into wild-
type CD45.2+ C57BL/6 mice on days 3 and 4 following UUO (total cells
injected = 15 × 106). The obstructed left kidney, sham controls and
draining lymph nodes were harvested on day 7 and either digested for
flow cytometric studies or snap frozen for immunofluorescent staining.
In some experiments, liver and spleen were harvested and en-
zymatically dissociated prior to flow cytometric studies.
2.12. Detection of CD45.1+ cells in the lymph node draining the kidney
Frozen sections of the draining lymph nodes were air dried for
30 min. and fixed in ice-cold acetone for 5 min. Tissue was blocked for
1 h with M.O.M.™ Ig Blocking Reagent (Vector) diluted in PBS, washed
in PBS, incubated for 5 min in the M.O.M.™ Diluent (Vector) before
incubating with mouse anti-mouse CD45.1 (Clone A20 Biolegend;
1:250 dilution in MOM diluent) for 1 h at room temperature. Slides
were washed, incubated in goat anti-mouse Alexa Fluor 488
(Invitrogen, 1:300 in Dako antibody diluent) for 30 min., washed and
mounted with Vetashield medium (plus DAPI for nuclear staining;
Vector). Images were captured using a Zeiss Axioskop 2mot +
microscope (Zeiss).
2.13. Statistical analysis
Data were analysed with Prism software (GraphPad). All values are
expressed as mean ± SEM. Unpaired Student’s t-test or ANOVA (Tukey
post-hoc test) were used for analysis. P-values < 0.05 denote statistical
significance, *p < 0.05, **p < 0.01, ***p < 0.005.
3. Results
3.1. GM-CSF treatment of macrophages induces DC characteristics
Initial experiments phenotyped BMMφ or BMDCs generated by
standard C57BL/6 bone marrow culture for 7 days in medium condi-
tioned with either M-CSF (Mφ medium) or GM-CSF (DC medium;
Supplementary Fig. 1a). Flow cytometry indicated that day 7 BMMφ
were F4/80HiCD11cLowClass IILow whilst day 7 BMDCs were F4/
80LowCD11cHiClass IIHi (Fig. 1a–c).
Day 7 BMMφ were then cultured for a further 5 days in either Mφ
medium (M-CSF) or DC medium (GM-CSF; Supplementary Fig. 1b) and
phenotyped by flow cytometry. Culture of F4/80HiCD11cLowClass IILow
BMMφ in DC medium resulted in reduced F4/80 expression and in-
creased CD11c expression with no change in Class II expression
(Fig. 1d–f). Analysis of primary peritoneal Mφ revealed a similar pat-
tern following 5 days treatment with DC medium (Supplementary
Fig. 2). Day 7 BMDC were also cultured for a further 5 days in either
Mφ medium or DC medium and phenotyped by flow cytometry (Sup-
plementary Fig. 1b). Culture of F4/80LowCD11cHiClass IIHi BMDCs in
Mφ medium resulted in increased F4/80 expression and reduced CD11c
and MHC Class II expression (Fig. 1d–f). Results similar to those above
were obtained using recombinant M-CSF and GM-CSF (Supplementary
Fig. 3), and using cells derived from FVBN/j bone marrow (data not
shown) suggesting that the modulatory effects were directly driven by
the growth/differentiation factors and were not unique to cells derived
from C57/BL6 mice.
Expression of CCR7 mRNA was high in d7 BMDCs and absent in d7
BMMφ (data not shown). Realtime PCR for CCR7 mRNA expression in
BMMφ was performed at days 8, 10 and 12 following the change of
medium at day 7 (Mφ→DC medium) and demonstrated a progressive
increase in CCR7 mRNA expression by BMMφ cultured in DC medium
reaching statistical significance by day 12 (Fig. 1g). In contrast, a
progressive loss of CCR7 expression was evident in BMDCs cultured in
Mφ medium (Fig. 1g). As expected, control day 7 BMMφ cultured in
Mφ medium for a further 5 days did not upregulate CCR7 mRNA ex-
pression whilst BMDCs cultured in DC medium for a further 5 days
exhibited an ongoing high level of CCR7 mRNA expression (Fig. 1g).
CCR7 expression is a feature of DCs as it facilitates the emigration of
DCs from tissues to lymph nodes. As well as this, DCs also have the
capacity to stimulate naïve allogeneic T cells. We therefore tested
whether the culture of BMMφ in DC medium induced the ability to
stimulate naïve allogeneic T cells. As shown in Fig. 1h, day 7 BMMφ
cultured in DC medium for 5 days acquired the ability to stimulate
naïve allogeneic T cells in a mixed leukocyte reaction (MLR). In con-
trast, day 7 BMDCs cultured in Mφ medium for 5 days exhibited a
significant reduction in the ability to drive T cell proliferation (Fig. 1h).
As expected, BMMφ or BMDCs maintained throughout in Mφ or DC
medium respectively for 12 days retained their characteristic pheno-
typic markers and functional properties (Fig. 1).
3.2. GM-CSF treatment reduces the phagocytic capacity of macrophages
The phagocytic ingestion of apoptotic cells and cell debris is a key
feature of both homeostatic and inflammatory Mφ, and plays an im-
portant role in tissue development, inflammation and healing (Elliott
et al., 2017). We therefore used a flow cytometric assay to examine
whether exposure to DC medium modulated Mφ phagocytosis of
CMgreen labelled apoptotic cells and fluorescent beads (Fig. 2a–h).
BMMφ cultured in Mφ medium for 12 days were markedly phagocytic
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with ∼80% of cells ingesting apoptotic cells or beads (Fig. 2a,c&e). The
culture of BMMφ in DC medium for 5 days significantly reduced the
level of phagocytosis of both apoptotic cells and fluorescent beads
(Fig. 2b,d,f–h).
3.3. Modulation of bone marrow-derived macrophages and dendritic cell
phenotype result from whole cell population changes
It was important to determine whether the modulatory effects of the
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5-day culture period in either Mφ or DC medium resulted from the
proliferation and outgrowth of a progenitor cell population present
within the initial day 7 BMMφ or BMDC population with the associated
death of established mature BMMφ or BMDC from day 7 onwards. We
therefore undertook a series of cell labeling studies to enable cells to be
tracked over time. BMMφ or BMDCs were labeled with PKH67 green
fluorescent dye at day 7 prior to medium switching or continuation for
a further 5 days. 95–98% of d7 BMMφ and BMDCs were labeled with
PKH67 green (Fig. 3a) with cells retaining the dye over the ensuing 5
days (Fig. 3b). Flow cytometry dot plots indicated that the entire po-
pulation of PKH labeled d7 BMMφ exhibited decreased F4/80 expres-
sion and increased CD11c expression following culture in DC medium
with the opposite results for BMDCs cultured in Mφ medium (Fig. 3b).
Thus, the induced phenotypic changes in BMMφ and BMDCs cultured in
DC medium or Mφ medium respectively resulted from whole popula-
tion shifts and not the rapid expansion of progenitor populations as-
sociated with the death of mature BMMφ and BMDCs from day 7 on-
wards.
3.4. Concurrent exposure to both GM-CSF and M-CSF modulates the
phenotype of macrophages and dendritic cells
The above experiments indicated that the in vitro phenotype of
mature BMMφ and BMDCs can be modulated by the discrete and sole
exposure to GM-CSF or M-CSF respectively. Although conditions in vitro
may be carefully controlled, monocytes recruited from the blood in vivo
are likely to be exposed to both M-CSF and GM-CSF during renal in-
flammation (Matsuda et al., 1996), as many renal cells may produce M-
CSF (Isbel et al., 2001a; Isbel et al., 2001b) and GM-CSF (Greiber et al.,
2002; Dudas et al., 2011). We hypothesized that the simultaneous ex-
posure to both M-CSF and GM-CSF would also act to modulate cell
phenotype and we therefore cultured bone marrow cells from the outset
in either Mφ medium, DC medium or a 50:50 mix of Mφ/DC media in
an attempt to simulate the exposure of monocytes to multiple signals
that might be found in the tissue environment. Cells that had been
exposed to the 50:50 mix Mφ/DC media for 7 days exhibited a phe-
notype somewhat intermediate between BMMφ and BMDCs being F4/
80MedCD11cMedClass IILow (Fig. 4a–c).
We then assessed the effect of simultaneous exposure to both M-CSF
and GM-CSF upon d7 mature BMMφ and BMDC by culturing them in
50:50 mix of Mφ/DC media for 5 days prior to phenotyping in an at-
tempt to simulate the exposure of mature tissue Mφ and DCs to multiple
signals that might be found in inflamed tissues. Intriguingly, BMMφ
cultured for 5 days in the 50:50 mix of Mφ/DC media exhibited reduced
F4/80, increased CD11c, reduced MHC Class II and increased CCR7
mRNA expression compared to control BMMφ (Fig. 4d-f&j). In contrast,
d7 BMDCs exposed to the 50:50 mix of Mφ/DC media for 5 days ex-
hibited reduced expression of MHC Class II and CCR7 mRNA and
comparable F4/80 and CD11c expression compared to control BMDCs
(Fig. 4h-i&k). The effect of such combinatorial stimuli upon phenotype
is complicated by the fact that GM-CSF can downregulate the expres-
sion of colony-stimulating factor-1 receptor (CSF1R) that binds M-CSF
and thus indirectly inhibit M-CSF signaling (Panterne et al., 1996).
Indeed, we noted that culture of BMMφ with DC medium for 5 days
reduced cell surface expression of CSF1R by ∼60% (data not shown).
3.5. The obstructed murine kidney expresses both M-CSF and GM-CSF
Since the phenotype of BMMφ and BMDCs is modulated by the
ambient M-CSF and GM-CSF levels in vitro, we determined the M-CSF
and GM-CSF protein levels by ELISA of kidney homogenates following
UUO. M-CSF and GM-CSF protein levels increased significantly by day 5
following UUO (Fig. 5a,b). The M-CSF/GM-CSF ratio following UUO
varied over multiple experiments (Fig. 5a, b and data not shown) with a
mean peak M-CSF/GM-CSF ratio of 30:1. Thus, although the obstructed
kidney is a M-CSF dominant microenvironment, recruited monocytes
would be exposed to low levels of GM-CSF.
3.6. Exposure to a 30:1 mix of recombinant M-CSF/GM-CSF modulates
macrophage phenotype
Bone marrow cells were cultured for 7 days in either recombinant
M-CSF (20 ng/ml), GM-CSF (667 pg/ml) or a 30:1 M-CSF/GM-CSF mix
(Both; 20 ng/ml M-CSF & 667 pg/ml GM-CSF). Cells cultured with M-
CSF generated F4/80HiCD11cLow cells whilst both GM-CSF and the M-
CSF/GM-CSF mix generated F4/80LowCD11cHi cells (Fig. 5c, d). MHC
Class II expression was low in all cells (Fig. 5e). The presence of GM-
CSF alone or with M-CSF induced significant expression of CCR7 mRNA
(Fig. 5f). Thus, some conventional characteristics of DCs can be induced
in vitro even when relatively small amounts of GM-CSF are present.
3.7. The phenotype of bone marrow-derived macrophages is modified
following adoptive transfer to mice with ureteric obstruction
We then asked whether such phenotypic changes might be induced
in exogenously administered BMMφ following recruitment to the ob-
structed kidney in vivo. A total of 15 × 106 CD45.1+ BMMφ was ad-
ministered to CD45.2+ mice (3 separate intravenous injections of
5 × 106 CD45.1+ BMMφ) on days 3 and 4 following UUO. Flow cy-
tometric analysis of digested kidneys indicated the presence of
CD45.1+ cells at day 7 with very few CD45.1+ cells evident at day 10
suggesting recruitment of administered CD45.1+ BMMφ at day 7 and
either death or egress from the kidney at d10 (Supplementary Fig. 4).
Compared to the CD45.1+ BMMφ administered at d 3-4, the CD45.1+
cells present in dissociated obstructed kidneys at day 7 expressed
comparable F4/80 expression, increased CD11c expression and mark-
edly increased MHC Class II expression (Fig. 6a–c). Additional experi-
ments were performed to examine the phenotype of CD45.1+ BMMφ
that had localized to other organs such as liver and spleen. In these
studies, the CD45.1+ cells present in the dissociated UUO kidneys at
day 7 expressed reduced F4/80 expression, increased CD11c and MHC
Class II expression compared to the CD45.1+ BMMφ administered at d
3-4 (Fig. 7a). Some modulation of phenotype was evident in other or-
gans but the renal phenotype was not recapitulated in CD45.1+ cells
isolated from liver or spleen (Fig. 7b). Since our in vitro data indicated
prominent upregulation of CCR7 mRNA expression by exposure of
BMMφ to GM-CSF, we examined the draining renal lymph nodes for the
presence of CD45.1+ cells that would suggest BMMφ egress from the
kidney. Immunofluorescent staining of the draining left renal hilar
lymph node of obstructed kidneys revealed the presence of CD45.1+
cells (Fig. 8) with no CD45.1+ cells found in lymph nodes of controls
that underwent sham surgery 3 days before the intravenous
Fig. 2. Culture in DC medium reduces macrophage phagocytosis of apoptotic cells and beads. Day 7 bone marrow-derived Mφ were incubated for 5 days in
macrophage (Mφ) or dendritic cell (DC) medium (n = 3 mice). Cells were then incubated with CellTracker Green labeled apoptotic murine thymocytes or 3 μm
Fluoresbrite YG microsphere beads for 60 min. Cells were vigorously washed and detached from the plates for flow cytometric assessment of the proportion of cells
that had phagocytosed apoptotic cells or beads. Representative flow cytometry dot plots of Mφ cultured in Mφ medium (cells alone (a), following incubation with
beads (c) or apoptotic cells (e)) or DC medium (cells alone (b), following incubation with beads (d) or apoptotic cells (f). Quantification of the proportion of cells
exhibiting phagocytosis demonstrates that Mφ cultured in Mφ medium (Mφ/Mφ) remain highly phagocytic but exhibit reduced phagocytic capacity following
incubation in DC medium (Mφ/DC) (g & h). ** p < 0.01, ***p < 0.001 (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article).
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administration of equal numbers of CD45.1+ BMMφ. This is supported
by evidence that CCR7 expression is increased in CD11b + mono-
nuclear phagocytes in the kidney after UUO (Supplementary Fig. 5).
4. Discussion
Mφ and DCs are extremely heterogeneous and display significant
plasticity due to stimuli present in their local environment (Hochheiser
et al., 2011; Mosser and Edwards, 2008; Davies et al., 2013). This work
supports the concept that colony stimulating factors play a crucial role
in mononuclear phagocyte phenotype in the kidney after injury (Isbel
et al., 2001a; Isbel et al., 2001b; Zhang et al., 2012; Wang et al., 2015;
Huen et al., 2015), and emphasizes a key role for GM-CSF.
Tubulointerstitial mononuclear phagocytes are part of the intricate
system that surveys against injury and infection (Weisheit et al., 2015),
and contributes to organ homeostasis and tissue repair (Wang and
Harris, 2011; Ferenbach et al., 2010; Rogers et al., 2014). These mye-
loid cells are crucial in the recovery of kidney function after injury, and
can dictate the balance between successful regeneration and pro-
gressive fibrosis (Rogers et al., 2014). Mφ are very responsive to their
environment and exhibit different states of maturity, activation, po-
larization and plasticity in vivo (Mosser and Edwards, 2008). For ex-
ample, Mφ may adopt a pro-inflammatory M1 or an anti-inflammatory
wound healing M2 phenotype (Nelson et al., 2012). M1 Mφ may evolve
into M2 Mφ following acute kidney injury (Lee et al., 2011), whilst M2
Mφ exhibit M1 features following LPS stimulation (Mylonas et al.,
2009). Whereas pro-inflammatory Mφ contribute to the initial kidney
damage, a M2 Mφ phenotype can promote normal renal repair. DCs are
closely related to Mφ, but are considered professional APCs, whose
main role is the activation and regulation of T cells. CCR7 is an im-
portant marker of DCs as it directs their emigration from tissues to-
wards the chemokines CCL19/21 in lymphatic tissue (Hirao et al.,
2000; Yu et al., 2008; Jakubzick et al., 2006).
Both M-CSF and GM-CSF were elevated during UUO. Therefore,
mononuclear phagocytes present in that environment are likely to be
exposed to both M-CSF and GM-CSF such that cells grown in either M-
CSF or GM-CSF are unlikely to have a counterpart in vivo. There is an
ongoing debate regarding the classification of mononuclear phagocyte
as either a Mφ or DC (Hume, 2008), and recent work indicates that both
these cells in the kidney may exhibit features previously ascribed to
either one or the other, e.g. expressing both F4/80 and CD11c (Cao
et al., 2015; Kruger et al., 2004; Bethunaickan et al., 2011). Thus, a
somewhat ‘hybrid’ cell, similar to the cells identified in our studies, may
well be present in vivo. Indeed, in the steady state, renal mononuclear
phagocytes share both Mφ and DC characteristics, appear to serve as
sentinels for the immune response, and play anti-inflammatory and
tissue-reparative roles (Kawakami et al., 2013). CD11c +
subpopulations of mononuclear phagocytes from the kidney, pre-
ferentially induce regulatory T cell differentiation upon presentation to
naïve T cells, implicating a role in immunological tolerance (Kawakami
et al., 2013).
During the inflammatory model of unilateral ureteric obstruction
(UUO), used in this study, the replacement of functional kidney tissue
with scarred tissue has been found to be highly dependent on Mφ, as
depletion of these cells with clodronate greatly reduces fibrosis
(Viehmann et al., 2018). CD11c + mononuclear phagocytes, histori-
cally described as ‘DCs’, have been found to play no role in the fibrotic
response during UUO but display enhanced antigen presentation to T
cells. Studies indicate that these antigen presenting CD11c + cells ac-
tually help reduce UUO-induced inflammation and fibrosis (Viehmann
et al., 2018), possibly through preferential promotion of regulatory T
cells in the lymphatics (Kawakami et al., 2013), although this requires
further investigation.
We found that M-CSF levels were greatly elevated by day 3 and
peaked at day 5 post-UUO. In tissue, production of M-CSF induces
monocyte recruitment from the blood and proliferation and survival of
tissue-resident Mφ. Indeed, previous studies in the kidney have found
that after renal injury, M-CSF produced specifically by tubular epithe-
lial cells is important for the proliferation of resident Mφ, and mono-
cyte recruitment (Zhang et al., 2012; Wang et al., 2015). In agreement
with this, we noted rising levels of M-CSF when Mφ/DC numbers were
increasing in the UUO kidney. We, and others (Smith et al., 2013), have
found that M-CSF also promotes phagocytosis. These actions of M-CSF
in an in vivo context likely contributes to apoptotic cell clearance and
M1 to M2 phenotypic switching, thus promoting the resolution of in-
flammation (Reviewed in Savill et al., 2002 and Elliott et al., 2017). In
support of this, Wang et al demonstrated that the absence of tubular
cell-derived M-CSF led to reduced phenotype switching of Mφ from an
M1 to a the M2 phenotype that is essential for effective renal repair
(Wang et al., 2015). Therefore, M-CSF is crucial for an increase in Mφ
numbers early post-injury, augmentation of phagocytosis and skewing
Fig. 2. (continued)
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Fig. 3. The phenotypic shifts of bone marrow-derived macrophages and dendritic cells are due to whole cell population changes and not to an outgrowth
of progenitor cells. Day 7 bone marrow derived macrophages (BMMφ) or dendritic cells (BMDC) were labeled with PKH green. Flow cytometry was carried out to
confirm that all cells were labeled with PKH dye (a). The labeled Mφ and DCs were then replated and cultured in either the same medium (control Mφ/Mφ and DC/
DC) or switched to the opposite medium (Mφ/DC and DC/Mφ) for a further 5 days. At day 12 cells were analysed by flow cytometry to assess the expression of F4/80
and CD11c (y-axis) and the presence of PKH green (x-axis) (b).
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Fig. 4. Exposure to a 50:50 mix of macrophage and dendritic cell medium modulates the phenotype of macrophages and dendritic cells. Bone marrow cells
were grown in either macrophage (Mφ) medium, DC medium or a 50:50 mix of Mφ and DC media (Mφ, DC or mix) for 7 days before prior to analysis of cell
expression of F4/80 (a), CD11c (b) and MHC Class II expression (c) by flow cytometry. The level of expression is expressed as mean fluorescent intensity (MFI). In
further experiments, day 7 bone marrow-derived Mφ were washed and incubated for a further 5 days in either Mφ medium (Mφ/Mφ), DC medium (Mφ/DC) or the
50:50 mix (Mφ/mix). Similarly, day 7 bone marrow-derived DCs were washed and incubated for a further 5 days in either DC medium (DC/DC), Mφ medium (DC/
Mφ) or the 50:50 mix (DC/mix). At day 12, cells were recovered and the expression of F4/80 (d, g), CD11c (e, h) and MHC Class II (f, i) was determined by flow
cytometry whilst real-time PCR was used to determine CCR7 mRNA expression (j, k). Results are representative of multiple experiments (> 3). * p < 0.05, **
p < 0.01, ***p < 0.001.
Fig. 5. The obstructed kidney expresses both M-CSF and GM-CSF with modulation of macrophage and dendritic cell phenotype by recombinant M-CSF and
GM-CSF. C57BL/6 mice underwent unilateral ureteric obstruction and kidneys were removed at days 3, 5 and 7 for protein extraction. The concentrations of M-CSF
(a) and GM-CSF (b) were determined by ELISA. Bone marrow cells were cultured for 7 days in either recombinant M-CSF (20 ng/ml), GM-CSF (667 pg/ml) or a 30:1
mix (both) of M-CSF and GM-CSF (20 ng/ml M-CSF: 667 pg/ml GM-CSF). At day 7, the expression of F4/80 (c), CD11c (d) and MHC Class II (e) was determined by
flow cytometry whilst real-time PCR was used to determine CCR7 mRNA expression (f). The level of expression is expressed as mean fluorescent intensity (MFI).
Results are representative of multiple experiments. * p < 0.05, ** p < 0.01, ***p < 0.001.
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towards a reparative M2 phenotype at later time-points.
GM-CSF is present at low levels in the steady state, but is induced by
inflammation, driving such ‘DC’ functions as chemotaxis (Shiomi and
Usui, 2015) and antigen presentation (Morrissey et al., 1987). Al-
though, reports suggest that GM-CSF drives M1 activation in vitro
(Brocheriou et al., 2011; Lacey et al., 2012; Fleetwood et al., 2007), it
has recently been found to be critically important for M2 Mφ activation
during kidney injury (Huen et al., 2015). The current study revealed
that the peak protein expression level of GM-CSF post-UUO (day 5), was
less than 4% of the expression level of M-CSF. However, our studies
indicated that relatively low levels GM-CSF exerted a dominant effect
over M-CSF on cellular phenotype in vitro. Mφ, initially cultured in M-
CSF and then exposed to DC medium, displayed decreased Mφ markers
and reduced phagocytic activity. The strong induction of CCR7 mRNA
in BMMφ by GM-CSF in vitro, coupled with detecting adoptively
transferred BMMφ in the draining renal lymph node in vivo suggests
that GM-CSF drives CCR7 up-regulation in vivo in Mφ, which promotes
egress from the kidney (Lan et al., 1993), as has been described for
foamy Mφ in atheroma (Trogan et al., 2006). This was supported by our
evidence that CCR7 expression is significantly increased in CD11b +
mononuclear phagocytes in the kidney after UUO.
GM-CSF may reduce the responsiveness of mononuclear phagocytes
to M-CSF. Cells differentiated in GM-CSF express splice variants of CSF-
1R (the receptor for M-CSF) that may encode a soluble decoy receptor
(Hume, 2008). GM-CSF can also promote the cleavage of cell surface
CSF-1R (Hiasa et al., 2009). This inevitably leads to disruption of M-CSF
signalling, resulting in GM-CSF exerting a dominant effect, as was
evident in this study at very low levels of GM-CSF relative to M-CSF.
Therefore, consistent with our current in vitro and in vivo findings
and the work of others (Zhang et al., 2012; Wang et al., 2015; Huen
et al., 2015; Savill et al., 2002; Elliott et al., 2017; Hiasa et al., 2009),
we propose the following roles of M- and GM-CSF following UUO- M-
CSF expression increases in tubules early after injury (by day 3) and
promotes the recruitment and proliferation of mononuclear phagocytes,
as part of the initial inflammatory response. By day 5 (Fig. 9) M-CSF
contributes to the switching of these inflammatory M1 Mφ to a wound
healing M2 phenotype. GM-CSF expression has also increased and
drives an M1 to M2 Mφ phenotypic shift (Fig. 9), promoting the re-
solution of inflammation. We propose that GM-CSF expression also
reduces the responsiveness of mononuclear phagocytes to M-CSF, thus
preventing further recruitment of monocytes/proliferation of resident
Mφ. GM-CSF also drives the upregulation of CCR7, which promotes the
egress of these cells from the inflamed kidney (Fig. 9), which may assist
in the dampening of UUO-induced inflammation and fibrosis by re-
moving inflammatory cells and/or potentially stimulating regulatory T
cells.
4.1. Conclusion
In conclusion, this study reinforces the concept that Mφ and mye-
loid DCs represent points on a continuum within the mononuclear
phagocyte system (Hume et al., 2002, Hume, 2008). We propose that
GM-CSF plays a key role in regulating mononuclear phagocyte plasti-
city during renal inflammation, even when present in relatively small
levels, and exerts actions that contributes to the resolution of in-
flammation and promotion of renal repair.
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Fig. 6. The phenotype of bone marrow-derived macrophages is modified following adoptive transfer to mice with ureteric obstruction. 15 × 106 mature
day 7 bone marrow-derived macrophages (BMMφ) generated from CD45.1+ C57BL/6 mice were intravenously administered to CD45.2+ C57BL/6 mice (WT C57BL/
6) in 3 separate injections 3–4 days following unilateral ureteric obstruction (UUO). Whole kidneys were recovered and enzymatically dissociated for flow cytometric
analysis at day 7 following UUO. Flow cytometry for F4/80 (a), CD11c (b) or MHC Class II (c) was undertaken on day 7 BMMφ on the day of injection and the CD45.1
cells from the digested kidneys. Representative histograms are shown (continuous line - day 7 injected BMMφ, dashed line - CD45.1 cells from obstructed kidney)
whilst the level of expression is expressed as mean fluorescent intensity (MFI). ** p < 0.01.
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Fig. 7. The phenotype of adoptively transferred bone
marrow-derived macrophages localizing to multiple or-
gans. Day 7 mature bone marrow-derived macrophages
(BMMφ) generated from CD45.1+ C57Bl/6 mice were in-
travenously administered to CD45.2+ animals (WT C57BL/6)
3–4 days after unilateral ureteric obstruction (UUO) had been
performed (total cells injected ∼15 × 106) in order to track
the fate of the injected BMMφ. The obstructed kidneys, liver,
spleen and draining lymph node were recovered at day 7 and
enzymatically dissociated for flow cytometric analysis of
CD45.1+ cells for expression of F4/80, CD11c, MHC Class II
and CD86 (the level of expression is quantified as mean
fluorescent intensity [MFI]). CD45.1+ cells that localized to
the obstructed kidney exhibited a reduction in F4/80, in-
creased CD11c and a striking increase in MHC Class II ex-
pression with no change in CD86 expression (a). This pheno-
type was not evident in CD45.1+ cells that localized to the
spleen (↓F4/80, CD11c & CD86) or liver (↓F4/80 & CD86, ↑
MHC Class II) (b). ** p < 0.01, ***p < 0.001.
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Fig. 8. Adoptively transferred bone marrow-derived macrophages localize to the draining renal lymph node in mice with ureteric obstruction. 15 × 106
mature day 7 bone marrow-derived macrophages (BMMφ) generated from CD45.1+ C57BL/6 mice were intravenously administered to CD45.2+ C57BL/6 mice (WT
C57BL/6) in 3 separate injections 3–4 days following unilateral ureteric obstruction (UUO). The lymph nodes draining the left kidney following UUO or sham surgery
were removed and CD45.1 expression detected by immunofluorescent microscopy (CD45.1 - Green, DAPI - blue) (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article).
Fig. 9. Schematic diagram of the potential
effects of M-CSF and GM-CSF upon macro-
phages in the obstructed kidney. M-CSF
contributes to the switch of M1 inflammatory
Mφ to a reparative M2 phenotype (a). GM-CSF,
despite being expressed at lower levels com-
pared to M-CSF, also contributes to the M1 to
M2 Mφ phenotypic shift (a). GM-CSF causes a
reduction of CSF1-R expression (b) possibly
through cleavage of the CSF1-R receptor (c).47
GM-CSF induces the upregulation of the che-
mokine receptor CCR7 in Mφ (d) thereby
promoting chemotaxis of Mφ to the chemo-
kines CCL19 and CCL21 expressed by lym-
phatic vessels (e). Thus may, GM-CSF promote
the egress of CCR7+ cells from the inflamed
kidney to draining lymph nodes.
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